Biologic drug survival rates in the era of anti-Il-17 antibodies: a time period-adjusted registry analysis.

In Dermatology
by ClinOwl

Drug survival rates reflect efficacy and safety and may be influenced by the availability of alternative treatment options. Little is known about time-dependent drug survival in psoriasis and the effect […]